Antitumor response of an ERBB2 amplified inflammatory breast carcinoma with EGFR mutation to the EGFR-TKI erlotinib
- Siraj M Ali
- , R Kathy Alpaugh
- , Jamie K Buell
- , Philip J Stephens
- , Jian Qin Michael Yu
- , Hong Wu
- , Christine N Hiemstra
- , Vincent A Miller
- , Doron Lipson
- , Gary A Palmer
- , Jeffrey S Ross
- , Massimo Cristofanilli
- Foundation Medicine
- Department of Pathology
- Albany Medical College
- Fox Chase Cancer Center
Research output: Contribution to journal › Article › peer-review
21
Scopus
citations